Advanced Search

Share

English Português

Home Most often read

Hematology, Transfusion and Cell Therapy

Hematology, Transfusion and Cell Therapy

ISSN: 2531-1379

Hematology, Transfusion and Cell Therapy is a quarterly scientific publication of the Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), Associazione Italo-Brasiliana di Ematologia (AIBE), Eurasian Hematology Oncology Group (EHOG), and Sociedade Brasileira de Oncologia Pediátrica (SOBOPE).

Hematology, Transfusion and Cell Therapy publishes original articles, review articles and case reports covering various areas in the field of hematology and hemotherapy. The journal was previously published, until 2016, as Revista Brasileira de Hematologia e Hemoterapia.

ISSN print: 2531-1379
ISSN online: 2531-1387

Published by Elsevier Editora Ltda, Rio de Janeiro, Brazil.

See more

Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular. HEMO 2024. List of conference abstracts.

Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular. HEMO 2024. List of conference abstracts.

Indexed in:

Scopus, Medline, Directory of Open Access Journals (DOAJ), PubMed Central (PMC), Emerging Sources Citation Index (ESCI), SCImago Journal Rank (SJR), SNIP

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

See more

Impact factor 2024

1.6

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2024

2.0

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2024

0.360

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2024

0.754

View more metrics

Open Access Option

Journal Information

Most often read

Vol. 47. Issue. 3

3056

Chronic lymphocytic leukemia diagnosis: how many more algorithms and scoring systems do we need?

Daniel Mazza Matos

Hematol Transfus Cell Ther. 2025;47:3668

3056

Full text access

Share

2779

Diagnosis and treatment of chronic lymphocytic leukemia: 2025 recommendations of the Brazilian Group of Chronic Lymphocytic Leukemia of the Brazilian Association of Hematology and Hemotherapy (ABHH)

Carlos Sérgio Chiattone, Fernanda de Morais Marques, Valeria Buccheri, Mihoko Yamamoto, Sergio Costa Fortier, Maura Rosane Valerio Ikoma-Colturato, Nelson Hamerschlak, Vera Lucia de Piratininga Figueiredo, ... Brazilian Group of Chronic Lymphocytic Leukemia

Hematol Transfus Cell Ther. 2025;47:103822

2779

Full text access

Share

2742

When innovation meets patient blood management – a new way to see bleeding

Guilherme Rabello, Rosangela Monteiro, Bianca Meneghini, Fabio Biscegli Jatene

Hematol Transfus Cell Ther. 2025;47:3691

2742

Full text access

Share

2739

An approach to autologous stem cell mobilization: trying to define good mobilizers

Sara Montolio Chiva, Paula Gomez Fernandez, Antonio Manuel Gutiérrez Garcia, Maria del Carmen Ballester Ruiz, Antonia Sampol Mayol, Albert Perez Montaña

Hematol Transfus Cell Ther. 2025;47:3688

2739

Full text access

Share

2729

Ponatinib in the treatment of patients with chronic myeloid leukemia and increased cardiovascular risk: A review of management strategies

Tomasz Sacha, Katarzyna Krawczyk

Hematol Transfus Cell Ther. 2025;47:3675

2729

Full text access

Share

2120

Is galactomannan a useful tool for triage and diagnosis of oral invasive aspergillosis?

Maria Júlia Pagliarone, Lara Maria Alencar Ramos Innocentini, Fernanda Bortolotto, Vanessa Tonetto Marques Galves, Hilton Marcos Alves Ricz, Tatiane Cristina Ferrari, Renato Luiz Guerino Cunha, Belinda Pinto Simões, Leandro Dorigan de Macedo

Hematol Transfus Cell Ther. 2025;47:3687

2120

Full text access

Share

2042

From the mechanism of action to clinical management: A review of cardiovascular toxicity in adult treated with CAR-T therapy

Frank Nunes, Breno Moreno de Gusmão, Franciely Bueno Wiginesk, Euler Manenti, Juliana Soares, Mizianne Garcia Freitas, Juliane Dantas Seabra-Garcez, Alexandre Manoel Varela, ... Ariane Vieira Scarlatelli Macedo

Hematol Transfus Cell Ther. 2025;47:3693

2042

Full text access

Share

1840

Lower doses of dacarbazine (modified BEACODD) as a safer strategy with equal effectiveness in an intensive treatment protocol of Hodgkin's lymphoma: a preliminary retrospective analysis of a single public center in Brazil

Larissa Hilario Dulley, Arthur Gomes Oliveira Braga, Guilherme Garcia Rodrigues, Sergio Costa Fortier, Carlos Sérgio Chiattone, Talita Maira Bueno da Silveira

Hematol Transfus Cell Ther. 2025;47:3682

1840

Full text access

Share

1733

Validation of an automated quality control method to test sterility of two advanced therapy medicinal products: Mesenchymal stromal cells and their extracellular vesicles

Carolina Kymie Vasques Nonaka, Zaquer Suzana Munhoz Costa-Ferro, Ana Carolina Palmeira Arraes, Thamires Lopes Weber, Luciana Souza de Aragão França, Katia Nunes Silva, Bruno Solano de Freitas Souza

Hematol Transfus Cell Ther. 2025;47:3727

1733

Full text access

Share

1645

Optimization of hydroxyurea in sickle cell disease in Brazil

Clarisse Lobo, Ana Cristina Silva-Pinto, Rodolfo Delfini Cançado

Hematol Transfus Cell Ther. 2025;47:103826

1645

Full text access

Share

1615

Blood storage effect of G6PD on RBC quality

Andrew Evans Cobbinah, Benedict Sackey, Mina Ofosu, Herbert Ekoe Dankluvi, Stephen Opoku, Ampa Davis Frank

Hematol Transfus Cell Ther. 2025;47:103733

1615

Full text access

Share

1595

Complex somatic mutation landscape in myeloid cells in a patient with VEXAS syndrome: First Brazilian case report

Fabíola Reis de Oliveira, Adriane Souza Lima, Carlos Roberto Faria, Thaise Oliveira Quaresma, Marcio M. Mourani, Lauro Wichert-Ana, Paulo Louzada, Fernanda Gutierrez-Rodrigues, ... Rodrigo T. Calado

Hematol Transfus Cell Ther. 2025;47:3686

1595

Full text access

Share

1472

Annualized bleeding rate in hemophilia A patients in Brazil: a systematic review

Alessandra NL Prezotti, Débora MC Rocha, Endi L. Galvão, Thaís Gimenez, Leo Sekine, Rodrigo A. Ribeiro, Elisa Sobreira

Hematol Transfus Cell Ther. 2025;47:103736

1472

Full text access

Share

1389

Impact of blueberry extract on hematological response in phenylhydrazine-induced hemolytic anemia

Daniela Drosdowski, Patrick Türck, Silvio Tasca, Gabriel de Lima Rosa, Edson Fernando Muller Guzzo, Sara Elis Bianchi, Adriana Simon Coitinho, Cristina Campos Carraro, ... Alex Sander da Rosa Araujo

Hematol Transfus Cell Ther. 2025;47:103744

1389

Full text access

Share

1372

STAT5B::RARα-positive acute promyelocytic leukemia: Role of next generation sequencing in detection of a rare malignancy

Indranil Dey, Sushant Vinarkar, Mayur Parihar, Deepak Kumar Mishra

Hematol Transfus Cell Ther. 2025;47:3726

1372

Full text access

Share

1215

Transmitted blood infections and emerging vector-borne diseases in blood donors in northern Portugal

Ana Mota, Margarida Fonseca Cardoso

Hematol Transfus Cell Ther. 2025;47:103734

1215

Full text access

Share

1164

Assessing the role of bronchoscopy in the management of patients with acute leukemia—a transversal study and proposal of evaluation

José Vanildo Rodrigues de Oliveira, Carlos Wilson de Alencar Cano, José Vivaldo Moreira Feitosa Júnior, Guilherme Carneiro Barreto, Fernanda Rodrigues Mendes, Raphael Costa Bandeira de Melo, Elvira Deolinda Rodrigues Pereira Velloso, Vanderson Rocha, ... Wellington Fernandes da Silva

Hematol Transfus Cell Ther. 2025;47:103741

1164

Full text access

Share

1056

A common ground: an in silico assessment of the sources of intrinsic ex vivo resistance to venetoclax in acute myeloid leukemia

Brunno Gilberto Santos de Macedo, Manuela Albuquerque de Melo, Diego Antonio Pereira-Martins, João Agostinho Machado-Neto, Fabiola Traina

Hematol Transfus Cell Ther. 2025;47:103758

1056

Full text access

Share

1048

Outcomes and vaccination patterns against COVID-19 in a cohort of sickle cell disease patients in the state of Rio de Janeiro

Claudia de Alvarenga Maximo, Jorge Francisco da Cunha Pinto, Fabiana Canedo Pinto, Patrícia Brasil

Hematol Transfus Cell Ther. 2025;47:103824

1048

Full text access

Share

1042

Rare case of discrepant ABO typing between mother and newborn caused by para-Bombay AB phenotype

Tatiane Aparecida de Paula Vendrame, Giovana Faria Devides, Nayara Morais Silva, Marcela Custódio Mendes, Márcia Léia Morais Sampaio, Marcia Miyuki Nakamura, Greice Ap.Chetta de Klerk, Lilian Castilho, ... Carine Prisco Arnoni

Hematol Transfus Cell Ther. 2025;47:103742

1042

Full text access

Share

Publish in

Hematology, Transfusion and Cell Therapy

Hematology, Transfusion and Cell Therapy is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.

Idiomas

Hematology, Transfusion and Cell Therapy

Home
All contents
Publish your article
About the journal
- Aims and scope
- Editorial Board
Metrics